Neuroendocrine prostate cancer (NEPC) represents one of the most formidable challenges in oncology today, owing to its aggressive behavior, resistance ...
A groundbreaking theranostic strategy targeting RET, an emergent biomarker specific to neuroendocrine prostate cancer (NEPC), promises to revolutionize the diagnosis ...
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!
